Two Delhi CGHS Doctors Suspended For Favouring Pharma Company

NEW DELHI : Two central government health scheme (CGHS) doctors have been suspended and few others may face disciplinary action for allegedly prescribing certain medicines to favour a particular pharmaceutical company.

According to official sources, the two chief medical officers – one posted at the CGHS dispensary in Shahdara and other one at Dwarka Sector 9 – were prescribing the drugs even though the same medicines were available at the CGHS central warehouse at affordable rates.

The action against the doctors comes after Union health minister Mansukh Mandaviya’s office received a complaint in this connection a couple of months ago.

The minister ordered an enquiry and the preliminary probe revealed severe violations in prescribing medicines and that a group of doctors were favouring a particular pharmaceutical company, an official source said on Sunday.

  • Related Posts

    Unnecessary use of steroid leads to risk of severe fungal infections: Doctors

    Pune:  After the use of steroids for routine viral fevers and mild respiratory infections has grown among people, doctors in the city warned that it could increase the risk of…

    Spurious cosmetic packaging factory busted in northwest Delhi

    New Delhi: In a significant breakthrough under ‘Operation Kavach,’ the Cyber Cell of the Crime Branch, Delhi, has unearthed a major illegal manufacturing unit involved in the fabrication of empty…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Unnecessary use of steroid leads to risk of severe fungal infections: Doctors

    Unnecessary use of steroid leads to risk of severe fungal infections: Doctors

    Spurious cosmetic packaging factory busted in northwest Delhi

    Spurious cosmetic packaging factory busted in northwest Delhi

    Drugs & Cosmetics Rules | 60-Day Sample Testing Mandatory; Web-Host Reports: Bombay HC Orders Strict Action Against Erring Officers

    Drugs & Cosmetics Rules | 60-Day Sample Testing Mandatory; Web-Host Reports: Bombay HC Orders Strict Action Against Erring Officers

    UP plans US FDA-accredited medical device testing lab

    UP plans US FDA-accredited medical device testing lab

    Patent rejected for MNC’s cancer drug, generics to follow

    Patent rejected for MNC’s cancer drug, generics to follow

    Zydus brings world’s first Nivolumab biosimilar to India

    Zydus brings world’s first Nivolumab biosimilar to India